The antihypertensive effect of fermented milk in individuals with prehypertension or borderline hypertension

Journal of Human Hypertension

Volumn 24, Issue 10, 2010, Pages 678-683

  Usinger, L ^a   Jensen, L T ^a   Flambard, B ^b   Linneberg, A ^a   Ibsen, H ^c  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b Health and Nutrition Division Chr Hansen   (Denmark)

^c HOLBÆK HOSPITAL   (Denmark)

Author keywords

24hBP; blood pressure; borderline hypertension; fermented milk; Lactobacillus helveticus

Indexed keywords

LIPID;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BORDERLINE HYPERTENSION; BORDERLINE HYPERTENSIVE RAT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FERMENTED PRODUCT; HEART RATE; HUMAN; IN VITRO STUDY; LACTOBACILLUS HELVETICUS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MILK; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SHAM FEEDING; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CULTURED MILK PRODUCTS; DENMARK; DOUBLE-BLIND METHOD; FEMALE; FERMENTATION; HEART RATE; HUMANS; HYPERTENSION; LACTOBACILLUS HELVETICUS; LIPIDS; MALE; MIDDLE AGED; PLACEBO EFFECT; PREHYPERTENSION; TIME FACTORS; TREATMENT FAILURE;

EID: 77956875694     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.4     Document Type: Article

References (29)

1. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17(2): 151-183.
2. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21(6): 1011-1053.
3. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 2006; 24(2): 215-233.
4. Massey LK. Dairy food consumption, blood pressure and stroke. J Nutr 2001; 131(7): 1875-1878.
5. Abbott RD, Curb JD, Rodriguez BL, Sharp DS, Burchfiel CM, Yano K. Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle-aged men. The Honolulu Heart Program. Stroke 1996; 27(5): 813-818.
6. Barr SI, McCarron DA, Heaney RP, wson-Hughes B, Berga SL, Stern JS et al. Effects of increased consumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk factors in healthy older adults. J Am Diet Assoc 2000; 100(7): 810-817.
7. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 2005; 28(12): 2926-2932.
8. FitzGerald RJ, Murray BA, Walsh DJ. Hypotensive peptides from milk proteins. J Nutr 2004; 134(4): 980S-988S.
9. Sipola M, Finckenberg P, Santisteban J, Korpela R, Vapaatalo H, Nurminen ML. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol 2001; 52(4 Part 2): 745-754.
10. Takano T. Anti-hypertensive activity of fermented dairy products containing biogenic peptides. Antonie Van Leeuwenhoek 2002; 82(1-4): 333-340.
11. Nurminen ML, Sipola M, Kaarto H, Pihlanto-Leppala A, Piilola K, Korpela R et al. Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci 2000; 66(16): 1535-1543.
12. Hayakawa K, Kimura M, Kamata K. Mechanism underlying gamma-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats. Eur J Pharmacol 2002; 438(1-2): 107-113.
13. Van de Water J. Yogurt and immunity: the benefits of fermented milk products that contain lactic acid bacteria. In: Farquhar WB, (ed). Handbook of Fermented Food. CRC Press: Boca Raton, FL, 2003 pp 113-144.
14. Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y. Effect of powdered fermented milk with lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 2005; 24(4): 257-265.
15. Engberink MF, Schouten EG, Kok FJ, van Mierlo LA, Brouwer IA, Geleijnse JM. Lactotripeptides show no effect on human blood pressure: results from a doubleblind randomized controlled trial. Hypertension 2008; 51(2): 399-405.
16. Inoue K, Shirai T, Ochiai H, Kasao M, Hayakawa K, Kimura M et al. Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr 2003; 57(3): 490-495.
17. Jauhiainen T, Vapaatalo H, Poussa T, Kyronpalo S, Rasmussen M, Korpela R. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens 2005; 18(12 Part 1): 1600-1605.
18. Kawase M, Hashimoto H, Hosoda M, Morita H, Hosono A. Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J Dairy Sci 2000; 83(2): 255-263.
19. Seppo L, Jauhiainen T, Poussa T, Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 2003; 77(2): 326-330.
20. Lee YM, Skurk T, Hennig M, Hauner H. Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. Eur J Nutr 2007; 46(1): 21-27.
21. Campo IS, Beghin JC. Dairy food consumption, production, and policy in Japan. Working Paper 05-WP 401. 1-8,2005.
22. van Mierlo LA, Koning MM, van der ZK, Draijer R. Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies. Am J Clin Nutr 2009; 89(2): 617-623.
23. Xu JY, Qin LQ, Wang PY, Li W, Chang C. Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 2008; 24(10): 933-940.
24. Mizuno S, Matsuura K, Gotou T, Nishimura S, Kajimoto O, Yabune M et al. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br J Nutr 2005; 94(1): 84-91.
25. Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 2000; 54(4): 288-297.
26. Usinger L, Ibsen H, Jensen LT. Does fermented milk possess antihypertensive effect in humans? J Hypertens 2009; 27(6): 1115-1120.
27. Foltz M, Meynen EE, Bianco V, van PC, Koning TM, Kloek J. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. J Nutr 2007; 137(4): 953-958.
28. Wuerzner G, Peyrard S, Blanchard A, Lalanne F, Azizi M. The lactotripeptides isoleucine-prolineproline and valine-proline-proline do not inhibit the N-or C-terminal angiotensin converting enzyme active sites in humans. J Hypertens 2009; 27(7): 1404-1409.
29. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360(9349): 1903-1913.